Ph II Gemcitabine, Erlotinib, and Gemcitabine With Erlotinib/Elderly Patients W/ IIIB/IV NSCLC

NCT00283244 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

147

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: erlotinib hydrochloride
DRUG: gemcitabine hydrochloride

Sponsor

UNC Lineberger Comprehensive Cancer Center

Collaborators

[object Object]